Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Pantel

Showing results (131-140 of 153) with videos related to

Pageof 16
Sort By:
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|July 1, 1997
Expression and prognostic significance of HLA class I, ICAM-1, and tumor-infiltrating lymphocytes in esophageal cancerS B Hosch, A J Meyer, C Schneider, et al.
Der Urologe. Ausg. A|October 27, 2017
[Metastatic castration-resistant prostate cancer : Use of cabazitaxel taking into consideration current data]J E Gschwend, P Albers, M Bögemann, et al.
The British Journal of Surgery|February 1, 1994
Radical systematic mediastinal lymphadenectomy in non-small cell lung cancer: a randomized controlled trialJ R Izbicki, O Thetter, M Habekost, et al.
Breast (Edinburgh, Scotland)|June 4, 2013
Patterns of metastatic spread in early breast cancerM B Klevesath, K Pantel, O Agbaje, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1996
Prognostic significance of bone marrow micrometastases in patients with gastric cancerK W Jauch, M M Heiss, U Gruetzner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 1998
Reduced expression of plakoglobin indicates an unfavorable prognosis in subsets of patients with non-small-cell lung cancerK Pantel, B Passlick, J Vogt, et al.
The New England Journal of Medicine|February 24, 2000
Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancerS Braun, K Pantel, P Müller, et al.
Blood|May 16, 2000
In vitro differentiation of endothelial cells from AC133-positive progenitor cellsU M Gehling, S Ergün, U Schumacher, et al.
Nature Communications|August 18, 2017
Mast cells decrease efficacy of anti-angiogenic therapy by secreting matrix-degrading granzyme BM Wroblewski, R Bauer, M Cubas Córdova, et al.
Clinical Genetics|February 27, 2016
Diverse prognostic value of the GTn promoter polymorphism in squamous cell and adeno carcinoma of the oesophagusT Ghadban, J T Miro, F Trump, et al.
Pageof 16

Showing results (131-140 of 153) with videos related to

Sort By:
Pageof 16
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|July 1, 1997
Expression and prognostic significance of HLA class I, ICAM-1, and tumor-infiltrating lymphocytes in esophageal cancerS B Hosch, A J Meyer, C Schneider, et al.
Der Urologe. Ausg. A|October 27, 2017
[Metastatic castration-resistant prostate cancer : Use of cabazitaxel taking into consideration current data]J E Gschwend, P Albers, M Bögemann, et al.
The British Journal of Surgery|February 1, 1994
Radical systematic mediastinal lymphadenectomy in non-small cell lung cancer: a randomized controlled trialJ R Izbicki, O Thetter, M Habekost, et al.
Breast (Edinburgh, Scotland)|June 4, 2013
Patterns of metastatic spread in early breast cancerM B Klevesath, K Pantel, O Agbaje, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1996
Prognostic significance of bone marrow micrometastases in patients with gastric cancerK W Jauch, M M Heiss, U Gruetzner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 1998
Reduced expression of plakoglobin indicates an unfavorable prognosis in subsets of patients with non-small-cell lung cancerK Pantel, B Passlick, J Vogt, et al.
The New England Journal of Medicine|February 24, 2000
Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancerS Braun, K Pantel, P Müller, et al.
Blood|May 16, 2000
In vitro differentiation of endothelial cells from AC133-positive progenitor cellsU M Gehling, S Ergün, U Schumacher, et al.
Nature Communications|August 18, 2017
Mast cells decrease efficacy of anti-angiogenic therapy by secreting matrix-degrading granzyme BM Wroblewski, R Bauer, M Cubas Córdova, et al.
Clinical Genetics|February 27, 2016
Diverse prognostic value of the GTn promoter polymorphism in squamous cell and adeno carcinoma of the oesophagusT Ghadban, J T Miro, F Trump, et al.
Pageof 16